Efectividad diagnóstica de la tomografía por emisión de positrones con18fluorodeoxiglucosa asociada a tomografía axial en la discriminación de benignidad o malignidad de las lesiones suprarrenales

Villar Del Moral, Jesús María; Muñoz Pérez, Nuria; Rodríguez Fernández, Antonio; Olmos Juárez, Erika; Moreno Cortés, Clotilde; Rodríguez González, Rubén; Martín Cano, Francisco Javier; Sánchez Sánchez, Rocío; Ferrón Orihuela, José Antonio.
Cir. Esp. (Ed. impr.) ; 88(4): 247-252, oct. 2010. tab
Artículo en Español | IBECS (España) | ID: ibc-135868

Documentos relacionados

  1. [Diagnostic efficacy and discriminatory capacity of positron emission tomography combined with axial tomography of adrenal lesions].
  2. Diagnostic performance of unenhanced computed tomography and <sup>18</sup> F-fluorodeoxyglucose positron emission tomography in indeterminate adrenal tumours.
  3. Diagnostic and prognostic value of 18F-FDG PET/CT in comparison with morphological imaging in primary adrenal gland malignancies - a multicenter experience.
  4. The clinical consequences of functional adrenal uptake in the absence of cross-sectional mass on FDG-PET/CT in oncology patients.
  5. Does 18F-FDG PET/CT add diagnostic accuracy in incidentally identified non-secreting adrenal tumours?
  6. Adrenal masses in patients with cancer: PET/CT characterization with combined CT histogram and standardized uptake value PET analysis.
  7. <sup>18</sup>F-FDG-PET/CT-based machine learning model evaluates indeterminate adrenal nodules in patients with extra-adrenal malignancies.
  8. High False Positivity in Positron Emission Tomography is a Potential Diagnostic Pitfall in Patients with Suspected Adrenal Metastasis.
  9. FDG-PET/CT and FLT-PET/CT for differentiating between lipid-poor benign and malignant adrenal tumours.
  10. Radiologically defined lipid-poor adrenal adenomas: histopathological characteristics.